Jihong Dai resumes & CV records
Resumes
Principal Scientist
Work:
Novartis
Principal Scientist
Principal Scientist
Jihong Dai
Jihong C Dai, Age 58Stanhope, NJ
Jihong Dai Phones & Addresses
Stanhope, NJ
213 Prestwick Way, Edison, NJ 08820 (732) 603-6583
23 Colonial Lake Dr, Lawrence Twp, NJ 08648
Lawrenceville, NJ
1502 Seneca Run, Ambler, PA 19002
Nutley, NJ
Montgomery, PA
Mentions for Jihong C Dai
Publications & IP owners
Us Patents
Ex-Vivo Treatment Of Peripheral Blood Leukocytes With Ifn-Lambda
US Patent:
2012005, Mar 8, 2012
Filed:
Oct 27, 2008
Appl. No.:
12/290052
Inventors:
Grant Gallagher - Milltown NJ, US
Joyce Eskdale - Milltown NJ, US
Shekar Srinivas - Princeton Junction NJ, US
Jihong Dai - Ambler PA, US
Nicholas Megjugorac - Lopatcong NJ, US
Grant E. Gallagher - Milltown NJ, US
Joyce Eskdale - Milltown NJ, US
Shekar Srinivas - Princeton Junction NJ, US
Jihong Dai - Ambler PA, US
Nicholas Megjugorac - Lopatcong NJ, US
Grant E. Gallagher - Milltown NJ, US
Assignee:
Medical Diagnostic Laboratories, LLC - Hamilton NJ
International Classification:
A61K 38/21
A61P 37/08
A61P 31/12
A61K 35/12
A61P 11/06
A61P 37/08
A61P 31/12
A61K 35/12
A61P 11/06
US Classification:
424 855, 424 9371
Abstract:
The present invention provides a method of treating Th2-associated diseases and disorders by modulating the expression or secretion of IL-4, IL-5 and IL-13 using interferon lambda (IFN-λ). For Th2-associated diseases and disorders, cells of a patient having a Th2-associated disease or disorder are treated ex vivo, with IFN-λ and returned to the patient. The present invention also provides a method of ex vivo treatment, in conjunction with co-administration of IFN-λ
Ex-Vivo Treatment Of Peripheral Blood Leukocytes With Ifn-Lambda
US Patent:
2014005, Feb 20, 2014
Filed:
Dec 13, 2012
Appl. No.:
13/713457
Inventors:
Grant Gallagher - Milltown NJ, US
Joyce Gallagher - Milltown NJ, US
Jihong Dai - Ambler PA, US
Nicholas Megjugorac - Lopatcong NJ, US
Grant E. Gallagher - Hamilton NJ, US
Joyce Gallagher - Milltown NJ, US
Jihong Dai - Ambler PA, US
Nicholas Megjugorac - Lopatcong NJ, US
Grant E. Gallagher - Hamilton NJ, US
Assignee:
Medical Diagnostic Laboratories, LLC - Hamilton NJ
International Classification:
A61K 35/14
A61K 38/21
A61K 38/21
US Classification:
424 855, 424 9371
Abstract:
The present invention provides a method of treating Th2-associated diseases and disorders by modulating the expression or secretion of IL-4, IL-5 and IL-13 using interferon lambda (IFN-λ). For Th2-associated diseases and disorders, cells of a patient having a Th2-associated disease or disorder are treated ex vivo, with IFN-λ and returned to the patient. The present invention also provides a method of ex vivo treatment, in conjunction with co-administration of IFN-λ
Possible Relatives
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.